Yun Xia

3.5k total citations · 2 hit papers
59 papers, 2.7k citations indexed

About

Yun Xia is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Yun Xia has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Neurology. Recurrent topics in Yun Xia's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and RNA modifications and cancer (5 papers). Yun Xia is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and RNA modifications and cancer (5 papers). Yun Xia collaborates with scholars based in China, United States and Denmark. Yun Xia's co-authors include Nian Xiong, Fang Wan, Jinsha Huang, Xiaofang Dai, Qi Han, Gang Wu, Hongxia Zhou, Jipeng Guo, Bing-Fei Xu and Zhenyu Li and has published in prestigious journals such as Nature Communications, PLoS ONE and Analytical Chemistry.

In The Last Decade

Yun Xia

57 papers receiving 2.7k citations

Hit Papers

Ferroptosis: A Novel Anti-tumor Action for Cisplatin 2017 2026 2020 2023 2017 2018 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ferroptosis: A Novel Anti-tumor Action for Cisplatin
    2017 606 citations Yun Xia et al. profile →
  2. Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
    2018 307 citations Kai Ma, Nian Xiong et al. Frontiers in Aging Neuroscience profile →

Peers

Yun Xia
Qianxue Chen China
Chao Jiang China
Małgorzata Burek Germany
Imola Wilhelm Hungary
Katrien De Bock Switzerland
Hugo González Chile
Paweł Grieb Poland
Qianxue Chen China
Yun Xia
Citations per year, relative to Yun Xia Yun Xia (= 1×) peers Qianxue Chen

Countries citing papers authored by Yun Xia

Since Specialization
Citations

This map shows the geographic impact of Yun Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Xia more than expected).

Fields of papers citing papers by Yun Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Xia. The network helps show where Yun Xia may publish in the future.

Co-authorship network of co-authors of Yun Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Xia. A scholar is included among the top collaborators of Yun Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Xia. Yun Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Linhai, Xiaoli Wang, Xiangning Liu, et al.. (2024). Isolation of anti-tumor monoclonal antibodies targeting on MICA/B α3 domain by single B cell technology for colon cancer therapy. Heliyon. 10(15). e35697–e35697. 2 indexed citations
2.
Gao, Yang, Jianjun Xu, Bin Yang, et al.. (2024). A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic‐Gas Therapy. Advanced Science. 11(14). e2307143–e2307143. 19 indexed citations
3.
4.
Kou, Liang, Xiaosa Chi, Yadi Sun, et al.. (2024). Circadian regulation of microglia function: Potential targets for treatment of Parkinson’s Disease. Ageing Research Reviews. 95. 102232–102232. 6 indexed citations
5.
6.
Li, Yunna, Yun Xia, Sijia Yin, et al.. (2021). Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease. Frontiers in Immunology. 12. 719807–719807. 137 indexed citations
7.
Dong, Fang, Shengnan Ruan, Jinlong Wang, et al.. (2020). M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2. Cell Death and Disease. 11(9). 728–728. 102 indexed citations
8.
Han, Chao, Nian Xiong, Xingfang Guo, et al.. (2019). Exosomes from patients with Parkinson’s disease are pathological in mice. Journal of Molecular Medicine. 97(9). 1329–1344. 76 indexed citations
9.
Yin, Sijia, Jinsha Huang, Nian Xiong, et al.. (2019). Immune Reconstitution Inflammatory Syndrome Secondary to Autoimmune Hemolytic Anemia and Cryptococcal Meningitis. Frontiers in Neurology. 10. 812–812. 1 indexed citations
10.
Cai, Xianyi, Yunlu Liu, Yiqiang Hu, et al.. (2018). ROS-mediated lysosomal membrane permeabilization is involved in bupivacaine-induced death of rabbit intervertebral disc cells. Redox Biology. 18. 65–76. 67 indexed citations
11.
Friedman, Adam A., Yun Xia, Lorenzo Trippa, et al.. (2017). Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations. Clinical Cancer Research. 23(16). 4680–4692. 5 indexed citations
12.
Xia, Yun, Xianyi Cai, Liling Zhang, et al.. (2017). RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro. Anti-Cancer Drugs. 28(5). 514–521. 23 indexed citations
13.
Shen, Yan, Xiaoming Liu, Xi Long, et al.. (2017). Novel VPS13A Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review. Frontiers in Aging Neuroscience. 9. 95–95. 7 indexed citations
14.
Shen, Yan, Xingfang Guo, Chao Han, et al.. (2017). The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease. Cellular and Molecular Life Sciences. 74(20). 3741–3768. 10 indexed citations
15.
Xia, Yun, Xianyi Cai, Liling Zhang, et al.. (2015). Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo. Molecular Cancer Therapeutics. 14(7). 1582–1590. 44 indexed citations
16.
Cai, Xianyi, Yunlu Liu, Wen Yang, et al.. (2015). Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma. Journal of Orthopaedic Research®. 34(6). 932–941. 87 indexed citations
17.
Hu, Xiao, Jie Yu, Xiang Zhou, et al.. (2014). Synergism between upregulation of Rab7 and inhibition of autophagic degradation caused by mycoplasma facilitates intracellular mycoplasma infection. Molecular Medicine Reports. 9(3). 793–800. 9 indexed citations
18.
Sun, Dongsheng, Hui Xie, & Yun Xia. (2013). A study on the inhibitory effect of polysaccharides from <i>Radix ranunculus ternate</i> on human breast cancer MCF-7 cell lines. African Journal of Traditional Complementary and Alternative Medicines. 10(6). 439–439. 11 indexed citations
19.
Xia, Yun, Lihong Wang, Lei Cao, Norihiko Okada, & Yoshio Miki. (2010). Immunohistochemical study of β-catenin and functionally related molecular markers in tongue squamous cell carcinoma and its correlation with cellular proliferation. Oncology Letters. 1(3). 437–443. 10 indexed citations
20.
Xia, Yun, Yaqun Wu, Xiaojun He, Jianping Gong, & Fa‐Zu Qiu. (2008). Effects of mitofusin-2 gene on cell proliferation and chemotherapy sensitivity of MCF-7. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(2). 185–189. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianxue Chen Breakdown of academic impact, for papers by Chao Jiang Breakdown of academic impact, for papers by Małgorzata Burek Breakdown of academic impact, for papers by Imola Wilhelm Breakdown of academic impact, for papers by Katrien De Bock Breakdown of academic impact, for papers by Hugo González Breakdown of academic impact, for papers by Paweł Grieb
Rankless by CCL
2026